Novo Nordisk CEO Mike Doustdar defended the drugmaker's decision to sue rival Eli Lilly over its weight-loss drug advertising. "I am a big fan of competition. I think competition has to be fierce, but ...

Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.

Maker of the popular medications Ozempic and Wegovy filed a lawsuit against Eli Lilly, accusing it of making deceptive advertising claims about its weight-loss drug Zepbound.

Novo is seeking to force Lilly to pull the disputed ads and run corrective ones as the companies compete for dominance in the booming obesity drug market.

Discover the most underrated Sam's Club products shoppers swear by—hidden gems that save money, boost convenience, and make your membership go further.

The maker of Ozempic and Wegovy says its competitor is misleading consumers by citing outdated weight-loss data in advertisements.

Two of the world's biggest pharmaceutical companies are headed to court after Novo Nordisk, the maker of Ozempic and a pioneer in diabetes and obesity treatments, sued rival Eli Lilly on Tuesday, ...

The clash between pharma titans Novo Nordisk and Eli Lilly just escalated from the pharmacy counter to the courtroom. Novo Nordisk Inc. filed a lawsuit in the U.S. District Court for the District of ...

Novo alleges Lilly compared the highest approved doses of its medicines with lower doses of Novo’s Wegovy and Ozempic while omitting newer, higher-dose versions that Novo says deliver greater weight ...

A rival drug maker is taking aim at Eli Lilly in a major lawsuit, claiming the company purposely used old data in an ad campaign to make its products sound superior to its competitor's.